Treatment of Tuberculosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
=== Drug Triclosan | Target Enoyl-Acyl-Carrier Protein Reductase=== | === Drug Triclosan | Target Enoyl-Acyl-Carrier Protein Reductase=== | ||
[[Enoyl-Acyl-Carrier Protein Reductase]] is a target of anti-bacterial drugs such as triclosan (TCL)<ref>PMID:19130456</ref>. These drugs are used against tuberculosis infection. <scene name='43/434541/Cv/10'>Enoyl-Acyl-Carrier Protein Reductase is a tetramer</scene> (PDB code [[3fne]]). InhA ENR <scene name='43/434541/Cv/11'>active site contains NAD and triclosan derivative</scene>. | [[Enoyl-Acyl-Carrier Protein Reductase]] is a target of anti-bacterial drugs such as triclosan (TCL)<ref>PMID:19130456</ref>. These drugs are used against tuberculosis infection. <scene name='43/434541/Cv/10'>Enoyl-Acyl-Carrier Protein Reductase is a tetramer</scene> (PDB code [[3fne]]). InhA ENR <scene name='43/434541/Cv/11'>active site contains NAD and triclosan derivative</scene>. | ||
=== Drug [[Bedaquiline]] | Target proton pump for ATP synthase of mycobacteria === | |||
</StructureSection> | </StructureSection> | ||